“Dexmedetomidine alleviates hippocampal neuronal damage in epilepsy through BDNF/TrkB pathway by inhibiting MeCP2”, IJBB, vol. 61, no. 4, pp. 241–251, Mar. 2024, doi: 10.56042/ijbb.v61i4.8422.